Dogwood Therapeutics Inc (DWTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,056 | -10,346 | -3,845 | -1,121 | -467 |
| Depreciation Amortization | N/A | 54 | 42 | 27 | 11 |
| Accounts payable and accrued liabilities | 531 | 52 | 156 | 135 | 74 |
| Other Working Capital | -2,081 | -974 | 253 | 59 | 179 |
| Other Operating Activity | -506 | 7,319 | 1,786 | -150 | -74 |
| Operating Cash Flow | $-5,112 | $-3,895 | $-1,609 | $-1,050 | $-277 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $0 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 1,994 | 1,994 | 1,869 | 1,163 |
| Debt Repayment | N/A | -63 | -58 | -45 | N/A |
| Common Stock Issued | 198 | 31,525 | N/A | N/A | N/A |
| Other Financing Activity | -295 | -75 | -138 | -35 | 0 |
| Financing Cash Flow | $-98 | $33,381 | $1,799 | $1,789 | $1,163 |
| Beginning Cash Position | 29,795 | 309 | 309 | 309 | 309 |
| End Cash Position | 24,586 | 29,795 | 499 | 1,049 | 1,195 |
| Net Cash Flow | $-5,210 | $29,486 | $190 | $739 | $885 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,112 | -3,895 | -1,609 | -1,050 | -277 |
| Free Cash Flow | -5,112 | -3,895 | -1,609 | -1,050 | -277 |